Discover a study showing how HCV eradication with antivirals during immunotherapy improves survival, liver function, and ...

Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

With more than 170 million individuals currently infected, HCV is a global pandemic, effecting approximately 3% of the entire world's population. HCV infection is a growing infectious disease pandemic ...

Providing immediate bedside HCV consultation at discharge from labor and delivery for women with HCV-affected pregnancies is associated with higher rates of treatment completion than referral for ...

Osaka, Japan - Hepatitis C virus (HCV) may cause chronic infection to the liver, which can result in irreversible liver damage and liver cancer. How HCV manages to evade the immune system to infect ...

Unlike HIV or HBV, HCV replicates its genome directly into RNA without a DNA intermediate, so it lacks a latent, nuclear form that defies ready immunological clearance. In order for the virus to exist ...

Women who were prescribed direct-acting antivirals prior to hospital discharge were more likely to complete their regimens.

Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...

Pelosi is a scientific manager and researcher. Perkins is a senior advisor in governance. Remak is a patient advocate. Seid is a vaccine program lead. Romanowska is a fact-checking expert addressing ...

Hepatitis C, a bloodborne virus that damages the liver, can cause cirrhosis, liver cancer, liver failure and death if left untreated. Despite the availability of highly effective treatments, the ...

Public comment period opens for proposed Medicaid work requirements. Chippewa Cree Tribe awarded $2.5 million for hepatitis C ...

This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis. Objectives: To estimate the ...